Jazz Pharmaceuticals’ Xywav Approved for Narcolepsy
The FDA required a boxed warning for the drug because of its potential for misuse and abuse.
Source: Devices & Diagnostics Letter
The FDA required a boxed warning for the drug because of its potential for misuse and abuse.
Source: Devices & Diagnostics Letter